198 related articles for article (PubMed ID: 30012903)
1. 11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome.
Yoshida T; Matsuzaki T; Miyado M; Saito K; Iwasa T; Matsubara Y; Ogata T; Irahara M; Fukami M
Endocr J; 2018 Oct; 65(10):979-990. PubMed ID: 30012903
[TBL] [Abstract][Full Text] [Related]
2. 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
O'Reilly MW; Kempegowda P; Jenkinson C; Taylor AE; Quanson JL; Storbeck KH; Arlt W
J Clin Endocrinol Metab; 2017 Mar; 102(3):840-848. PubMed ID: 27901631
[TBL] [Abstract][Full Text] [Related]
3. 11-Oxygenated C19 Steroids Do Not Distinguish the Hyperandrogenic Phenotype of PCOS Daughters from Girls with Obesity.
Torchen LC; Sisk R; Legro RS; Turcu AF; Auchus RJ; Dunaif A
J Clin Endocrinol Metab; 2020 Nov; 105(11):e3903-9. PubMed ID: 32797203
[TBL] [Abstract][Full Text] [Related]
4. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
[TBL] [Abstract][Full Text] [Related]
5. Steroidogenic pathways involved in androgen biosynthesis in eumenorrheic women and patients with polycystic ovary syndrome.
Saito K; Matsuzaki T; Iwasa T; Miyado M; Saito H; Hasegawa T; Homma K; Inoue E; Miyashiro Y; Kubota T; Irahara M; Ogata T; Fukami M
J Steroid Biochem Mol Biol; 2016 Apr; 158():31-37. PubMed ID: 26877255
[TBL] [Abstract][Full Text] [Related]
6. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
7. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of 11-oxygenated androgens.
Turcu AF; Auchus RJ
Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):252-259. PubMed ID: 28234803
[TBL] [Abstract][Full Text] [Related]
9. Androgens During the Reproductive Years: What Is Normal for Women?
Skiba MA; Bell RJ; Islam RM; Handelsman DJ; Desai R; Davis SR
J Clin Endocrinol Metab; 2019 Nov; 104(11):5382-5392. PubMed ID: 31390028
[TBL] [Abstract][Full Text] [Related]
10. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
11. Inefficient UGT-conjugation of adrenal 11β-hydroxyandrostenedione metabolites highlights C11-oxy C
du Toit T; Swart AC
Mol Cell Endocrinol; 2018 Feb; 461():265-276. PubMed ID: 28939401
[TBL] [Abstract][Full Text] [Related]
12. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
13. The serum steroid signature of PCOS hints at the involvement of novel pathways for excess androgen biosynthesis.
Altinkilic EM; du Toit T; Sakin Ö; Attar R; Groessl M; Flück CE
J Steroid Biochem Mol Biol; 2023 Oct; 233():106366. PubMed ID: 37499841
[TBL] [Abstract][Full Text] [Related]
14. Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome.
Chen MJ; Han DS; Yang JH; Yang YS; Ho HN; Yang WS
Hum Reprod; 2012 Aug; 27(8):2476-83. PubMed ID: 22693174
[TBL] [Abstract][Full Text] [Related]
15. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.
Handelsman DJ; Teede HJ; Desai R; Norman RJ; Moran LJ
Hum Reprod; 2017 Feb; 32(2):418-422. PubMed ID: 27999117
[TBL] [Abstract][Full Text] [Related]
16. Excess 11-Oxygenated Androgens in Women With Severe Insulin Resistance Are Mediated by Adrenal Insulin Receptor Signaling.
Walzer D; Turcu AF; Jha S; Abel BS; Auchus RJ; Merke DP; Brown RJ
J Clin Endocrinol Metab; 2022 Aug; 107(9):2626-2635. PubMed ID: 35696182
[TBL] [Abstract][Full Text] [Related]
17. A new dawn for androgens: Novel lessons from 11-oxygenated C19 steroids.
Pretorius E; Arlt W; Storbeck KH
Mol Cell Endocrinol; 2017 Feb; 441():76-85. PubMed ID: 27519632
[TBL] [Abstract][Full Text] [Related]
18. Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency.
Turcu AF; Nanba AT; Chomic R; Upadhyay SK; Giordano TJ; Shields JJ; Merke DP; Rainey WE; Auchus RJ
Eur J Endocrinol; 2016 May; 174(5):601-9. PubMed ID: 26865584
[TBL] [Abstract][Full Text] [Related]
19. Steroid hormone analysis of adolescents and young women with polycystic ovarian syndrome and adrenocortical dysfunction using UPC
Swart AC; du Toit T; Gourgari E; Kidd M; Keil M; Faucz FR; Stratakis CA
Pediatr Res; 2021 Jan; 89(1):118-126. PubMed ID: 32247282
[TBL] [Abstract][Full Text] [Related]
20. Sex Differences in 11-Oxygenated Androgen Patterns Across Adulthood.
Davio A; Woolcock H; Nanba AT; Rege J; O'Day P; Ren J; Zhao L; Ebina H; Auchus R; Rainey WE; Turcu AF
J Clin Endocrinol Metab; 2020 Aug; 105(8):e2921-9. PubMed ID: 32498089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
